Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Carmustine Emcure


Contraindicated
Genotoxic

Contraindicated
Carmustine Emcure :
Type TAU
Originator Bicnu
Agent Pharmamed
Distributor Pharmamed
Laboratory Emcure
Manufacturer Emcure Pharmaceuticals Ltd
Manufacturing Type G
Origin India
ATC L01AD01

Your comment will appear shortly after approval

Carmustine Emcure :

Revision Date : 24/03/2026


Effect Frequency
Acute leukaemia Common
Alopecia Common
Anaemia Common
Anorexia Common
Ataxia Very Common
Bone marrow failure (Myelosuppression) Very Common
Conjunctival redness (conjunctival flushing ) Very Common
Constipation Common
Dermatitis Very Common
Diarrhoea (Diarrhea) Common
Dizziness Very Common
Encephalopathy Common
Flushing Common
Grand mal seizure Not known
Gynecomastia (Gynaecomastia) Rare
Headache Very Common
Hepatotoxicity (liver toxicity) Common
Hypokalaemia (hypokalemia) Not known
Hypomagnesaemia (hypomagnesemia) Not known
Hypophosphataemia (hypophosphatemia) Not known
Hypotension Very Common
Infertility Not known
Injection site reaction Common
Lung fibrosis interstitial Very Common
Myalgia Not known
Myelodysplasia (bone marrow dysplasia) Common
Nausea Very Common
Ocular toxicity Very Common
Phlebitis Very Common
Pneumonitis Very Common
Pulmonary toxicity Very Common
Renal toxicity Rare
Retinal haemorrhage (retinal hemorrhages) Very Common
Seizures Not known
Skin hyperpigmentation Very Common
Status epilepticus Not known
Stomatitis Common
Tachycardia Not known
teratogenesis Not known
Veno-occlusive disease Rare
Vision blurred Very Common
Vomiting Very Common

Different Units By MoH Code

Carmustine Emcure  MoH 2062254 :
Form Powder and solvent for concentrate for solution for infusion
Packaging Vial (Type II Glass) + Vial (Type I Glass)
Package Size 1+1x3ml
Strength 100mg
Storage Condition 2-8°C protect from light
Stratum N/A
NSSF ✘
Quarantine ✘


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info